Latest hyperglycemia Stories
THE WOODLANDS, Texas, Jan. 20 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc.
Two studies report that scientists have uncovered new genes linked to type 2 diabetes.
-- Partnership to develop automated system to better control diabetes represents first step on path to artificial pancreas -- NEW YORK, Jan.
A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general.
Insufficient trials -- no conclusions possible on diabetes-related diseases.
Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels.
Taste stimulation and its anticipation activates muscle glucose metabolism via 'orexin' neurons in the brain and thereby reduces blood glucose level in mice.
CARLSBAD, Calif., Oct. 13 /PRNewswire/ -- Luminous Medical, Inc. announced today that it has reached agreement with a major supplier of electrochemical sensors for exclusive rights to incorporate its glucose sensor into Luminous' automated blood glucose monitor.
PARIS, September 30 /PRNewswire-FirstCall/ -- - 76% Higher Dose of Insulin detemir Needed to Achieve Similar, Well Tolerated Glycemic Control Versus Lantus(R) Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today results of a head-to-head study providing further evidence on the efficacy of once-daily, 24-hour basal insulin Lantus(R) (insulin glargine [rDNA] injection) compared to twice-daily insulin detemir.
Studies link improvements in diabetes control to frequency of use and demonstrate continued improvements 12 months after use, with 'remarkably low' occurrence of severe hypoglycemia.
- To give a box on the ear to.